Ayse Sever

Ayse Sever has extensive experience in financial management and analysis, currently serving as Head of FP&A R&D and CFO New Meds at UCB since September 2002. Ayse's previous roles at UCB include A.Finance Director for Turkey, the Middle East & Africa, Controller for Europe Mid Markets, and various managerial positions in financial planning and analysis. Prior to UCB, Ayse worked at IKSIR ULUSLARARASI ELEKTRONIK TICARET as Assistant Business Controller and at Ernst & Young as Assistant Auditor. Ayse holds a degree from the University of California, Riverside and a Bachelor's degree from the University of Istanbul.